Literature DB >> 1340161

Status of ribozyme and antisense-based developmental approaches for anti-HIV-1 therapy.

J A Zaia1, S Chatterjee, K K Wong, D Elkins, N R Taylor, J J Rossi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1340161     DOI： 10.1111/j.1749-6632.1992.tb21062.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  3 in total

1.  New modalities in oncology: ribozymes.

Authors:  C Casey Cunningham
Journal:  Proc (Bayl Univ Med Cent)       Date:  2002-07

Review 2.  Cell-type-specific aptamer and aptamer-small interfering RNA conjugates for targeted human immunodeficiency virus type 1 therapy.

Authors:  Jiehua Zhou; John Rossi
Journal:  J Investig Med       Date:  2014-10       Impact factor: 2.895

3.  Efficient gene transfer into nondividing cells by adeno-associated virus-based vectors.

Authors:  G Podsakoff; K K Wong; S Chatterjee
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.